Literature DB >> 18190568

Biofilm formation in Acinetobacter baumannii: associated features and clinical implications.

J Rodríguez-Baño1, S Martí, S Soto, F Fernández-Cuenca, J M Cisneros, J Pachón, A Pascual, L Martínez-Martínez, C McQueary, L A Actis, J Vila.   

Abstract

Biofilm formation in 92 unrelated strains of Acinetobacter baumannii isolated in a multicentre cohort study was investigated using a microtitre plate assay. Fifty-six (63%) isolates formed biofilm. These isolates were less frequently resistant to imipenem or ciprofloxacin than were non-biofilm-forming isolates (25% vs. 47%, p 0.04; and 66% vs. 94%, p 0.004, respectively). All catheter-related urinary or bloodstream infections and the sole case of shunt-related meningitis were caused by biofilm-forming strains. Multivariate analysis revealed that treatment in an intensive care unit, ciprofloxacin resistance and isolation from a respiratory sample were associated with non-biofilm-forming isolates, while previous aminoglycoside use was associated with biofilm-forming isolates.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18190568     DOI: 10.1111/j.1469-0691.2007.01916.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  76 in total

Review 1.  Why are we afraid of Acinetobacter baumannii?

Authors:  Federico Perez; Andrea Endimiani; Robert A Bonomo
Journal:  Expert Rev Anti Infect Ther       Date:  2008-06       Impact factor: 5.091

2.  Photodynamic therapy for Acinetobacter baumannii burn infections in mice.

Authors:  Tianhong Dai; George P Tegos; Zongshun Lu; Liyi Huang; Timur Zhiyentayev; Michael J Franklin; David G Baer; Michael R Hamblin
Journal:  Antimicrob Agents Chemother       Date:  2009-06-29       Impact factor: 5.191

3.  Penetration of intact blood-brain barrier by doripenem.

Authors:  K Margetis; E Dimaraki; G Charkoftaki; E Vryonis; S Markantonis; N Boutos; H Archontaki; D E Sakas; G Valsami; A Skoutelis
Journal:  Antimicrob Agents Chemother       Date:  2011-05-09       Impact factor: 5.191

4.  Osmotic Compounds Enhance Antibiotic Efficacy against Acinetobacter baumannii Biofilm Communities.

Authors:  Azeza Falghoush; Haluk Beyenal; Thomas E Besser; Anders Omsland; Douglas R Call
Journal:  Appl Environ Microbiol       Date:  2017-09-15       Impact factor: 4.792

5.  Growth in glucose-based medium and exposure to subinhibitory concentrations of imipenem induce biofilm formation in a multidrug-resistant clinical isolate of Acinetobacter baumannii.

Authors:  Elisabetta Nucleo; Laura Steffanoni; Giulia Fugazza; Roberta Migliavacca; Ernesto Giacobone; Antonella Navarra; Laura Pagani; Paolo Landini
Journal:  BMC Microbiol       Date:  2009-12-22       Impact factor: 3.605

6.  Biofilm Formation Caused by Clinical Acinetobacter baumannii Isolates Is Associated with Overexpression of the AdeFGH Efflux Pump.

Authors:  Xinlong He; Feng Lu; Fenglai Yuan; Donglin Jiang; Peng Zhao; Jie Zhu; Huali Cheng; Jun Cao; Guozhong Lu
Journal:  Antimicrob Agents Chemother       Date:  2015-06-01       Impact factor: 5.191

7.  Outer membrane Protein A plays a role in pathogenesis of Acinetobacter nosocomialis.

Authors:  Sang Woo Kim; Man Hwan Oh; So Hyun Jun; Hyejin Jeon; Seung Il Kim; Kwangho Kim; Yoo Chul Lee; Je Chul Lee
Journal:  Virulence       Date:  2016-01-13       Impact factor: 5.882

8.  Molecular Analysis and Expression of bap Gene in Biofilm-Forming Multi-Drug-Resistant Acinetobacter baumannii.

Authors:  Omid Azizi; Fereshteh Shahcheraghi; Himen Salimizand; Farzan Modarresi; Mohammad Reza Shakibaie; Shahla Mansouri; Rashid Ramazanzadeh; Farzad Badmasti; Vajihe Nikbin
Journal:  Rep Biochem Mol Biol       Date:  2016-10

9.  Multidrug resistant acinetobacter.

Authors:  Vikas Manchanda; Sinha Sanchaita; Np Singh
Journal:  J Glob Infect Dis       Date:  2010-09

10.  Synergistic effects and antibiofilm properties of chimeric peptides against multidrug-resistant Acinetobacter baumannii strains.

Authors:  Ramamourthy Gopal; Young Gwon Kim; Jun Ho Lee; Seog Ki Lee; Jeong Don Chae; Byoung Kwan Son; Chang Ho Seo; Yoonkyung Park
Journal:  Antimicrob Agents Chemother       Date:  2013-12-23       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.